Physician profile
James D Gallagher
NPI 1215078217
$3,215.42
in general payments reported to CMS, 2019-2025
6 companies · $1,307 in 2025
The $1,307 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $119 · 2022: $267 · 2023: $1,523 · 2025: $1,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,221 · Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,220.75 |
| Food and Beverage | $609.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,578.76 | 2022-2023 | |
| Abbott Laboratories | $940.95 | 2025 | Aveir |
| Polynovo North America LLC | $290.85 | 2025 | Novosorb Btm |
| Medtronic, INC. | $210.91 | 2022-2023 | Azure Xt Dr Mri Surescan |
| Biosense Webster, INC. | $118.63 | 2020 | |
| Urgo Medical North America, LLC | $75.32 | 2025 | Urgoclean Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gallagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.